DS
ARAV

David Shaw’s Aravive, Inc. Common Stock ARAV Stock Holding History

David Shaw’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-20,637
Closed -$73K – 4006
2018
Q4 		$73K Sell
20,637
-14,574
-41% -$83.8K ﹤0.01% 3665
2018
Q3 		$295K Buy
35,211
+5,693
+19% +$60K ﹤0.01% 3369
2018
Q2 		$359K Buy
29,518
+13,532
+85% +$139K ﹤0.01% 3286
2018
Q1 		$158K Buy
15,986
+9,431
+144% +$106K ﹤0.01% 3361
2017
Q4 		$87K Buy
+6,555
New +$84.4K ﹤0.01% 3501
2017
Q2 		– Sell
-4,889
Closed -$626K – 3587
2017
Q1 		$626K Buy
4,889
+2,352
+93% +$248K ﹤0.01% 2610
2016
Q4 		$227K Sell
2,537
-185
-7% -$14K ﹤0.01% 3227
2016
Q3 		$200K Sell
2,722
-1,620
-37% -$117K ﹤0.01% 3201
2016
Q2 		$288K Sell
4,342
-1,694
-28% -$96.3K ﹤0.01% 3036
2016
Q1 		$290K Buy
+6,036
New +$320K ﹤0.01% 3031
2015
Q3 		– Sell
-2,574
Closed -$235K – 3951
2015
Q2 		$235K Buy
+2,574
New +$261K ﹤0.01% 3516

Other funds holding ARAV

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

David Shaw's ARAV Position: Q1 2019 in Review

David Shaw sold out of Aravive, Inc. Common Stock (ARAV) in Q1 2019, closing a stake of 20,637 shares — an estimated $73K sold.

David Shaw first reported a position in ARAV in Q2 2015 and held it in 11 quarters. The position peaked at $626K in Q1 2017. 30 funds tracked by Wall St. Rank hold ARAV as of Q1 2019.

  • David Shaw reported no remaining Aravive, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • David Shaw sold 20,637 Aravive, Inc. Common Stock shares in Q1 2019, an estimated $73K.
  • David Shaw first reported a position in Aravive, Inc. Common Stock in Q2 2015 and held it in 11 quarters.
  • David Shaw's Aravive, Inc. Common Stock position peaked at $626K in Q1 2017.
  • 30 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q1 2019.

Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.